Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FLT3 mutation + NRAS mutation
i
Other names:
FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2, NRAS1, N-Ras Protein Part 4, Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog, NRAS, Neuroblastoma RAS Viral Oncogene Homolog, NRAS Proto-Oncogene, GTPase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2322
;
4893
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
NRAS mutation (125)
FLT3-ITD mutation (90)
FLT3 mutation (67)
RAS wild-type (17)
NRAS Q61K (15)
FLT3-TKD mutation (13)
FLT3 D835Y (12)
FLT3 F691L (11)
NRAS Q61 (10)
NRAS wild-type (10)
NRAS Q61R (9)
FLT3 D835 (8)
NRAS G12D (7)
FLT3 D835V (6)
FLT3-ITD mutation + FLT3-TKD mutation (5)
NRAS G12 (5)
NRAS G13 (5)
NRAS Q61L (5)
DNMT3A mutation + FLT3-ITD mutation (4)
FLT3 D698N (4)
FLT3 D835H (4)
FLT3 G697R (4)
FLT3 N676K (4)
FLT3 Y842C (4)
FLT3 mutation + NPM1 mutation (4)
NRAS Q61H (4)
NRAS mutation + BRAF mutation (4)
FLT3 N676D (3)
FLT3 N676D + FLT3 Y842C (3)
FLT3 N676T (3)
FLT3 mutation + DNMT3A mutation (3)
FLT3 wild-type (3)
FLT3-ITD mutation + FLT3 D835 (3)
FLT3-ITD mutation + MLL rearrangement (3)
FLT3-ITD mutation + NPM1 mutation (3)
FLT3‐ITD + NPM1 mutation (3)
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)
NRAS A146T (3)
NRAS G13D (3)
NRAS G13N (3)
NRAS G13R (3)
NRAS Q61K + BRAF V600E (3)
NRAS exon 2 mutation (3)
NRAS exon 4 mutation (3)
FLT3 D835A (2)
FLT3 D835F (2)
FLT3 D835N (2)
FLT3 I836 (2)
FLT3 Y842H (2)
FLT3 mutation + MLL mutation (2)
FLT3-ITD mutation + FLT3 D835Y (2)
FLT3-ITD mutation + FLT3 F691L (2)
FLT3-ITD mutation + IDH1 mutation (2)
FLT3-ITD mutation + IDH2 mutation (2)
FLT3-ITD mutation + WT1 mutation (2)
FLT3‐ITD (2)
EGFR mutation + NRAS Q61K (2)
NRAS A146 (2)
NRAS A59 (2)
NRAS G12C + BRAF mutation (2)
NRAS H117 (2)
NRAS exon 3 mutation (2)
CEBPZ rearrangement + FLT3-TKD mutation (1)
FLT3 840GS (1)
FLT3 A627T (1)
FLT3 D651G (1)
FLT3 D835E (1)
FLT3 D835G (1)
FLT3 D839G (1)
FLT3 E588_Y589INSKYFYVDFRE (1)
FLT3 F691L + FLT3 D835F (1)
FLT3 F691L + FLT3 D835H (1)
FLT3 F691L + FLT3 D835V (1)
FLT3 F691L + FLT3 D835Y (1)
FLT3 F691L + FLT3 D839G (1)
FLT3 F691L + FLT3 Y842C (1)
FLT3 G619C (1)
FLT3 G846S (1)
FLT3 I687F (1)
FLT3 NPOS + FLT3 D835N (1)
FLT3 V592A + FLT3 D835N (1)
FLT3 V592_D593INSDFREY (1)
FLT3 Y591_V592INSVDFREYE (1)
FLT3 mutation + IDH1 mutation (1)
FLT3 mutation + NRAS mutation + PTPN11 mutation (1)
FLT3 mutation + PTPN11 mutation (1)
FLT3 positive (1)
FLT3-ITD F692L + NPM1 mutation (1)
FLT3-ITD mutation + ASXL1 mutation (1)
FLT3-ITD mutation + ASXL1 mutation + NRAS mutation (1)
FLT3-ITD mutation + DNMT3A mutation + ASXL1 mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation + FLT3 D835Y + FLT3 F691L (1)
FLT3-ITD mutation + NRAS mutation + GATA2 mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
FLT3‐ITD + DNMT3A mutation (1)
FLT3‐ITD + WT1 mutation (1)
MLL rearrangement + FLT3 mutation (1)
NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)
NPM1 mutation + FLT3-TKD mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
ARAF mutation + NRAS mutation (1)
ASXL1 mutation + NRAS mutation (1)
BRAF wild-type + NRAS wild-type (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + NRAS mutation (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
HRAS Q61L + NRAS Q61K (1)
IDH2 mutation + NRAS mutation (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
NPM1 mutation + NRAS mutation (1)
NRAS G115Efs*46 (1)
NRAS G12C + BRAF V600E + BRAF V600D (1)
NRAS G12S (1)
NRAS G12V (1)
NRAS G13D + BRAF V600E (1)
NRAS Q60H (1)
NRAS mutation + U2AF1 mutation (1)
SETBP1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
TET2 mutation + NRAS mutation (1)
FLT3 A848P (0)
FLT3 F691I (0)
FLT3 F691L + FLT3 Y842H (0)
FLT3 V592A (0)
FLT3-ITD F692L (0)
NRAS G12C (0)
NRAS mutation (125)
FLT3-ITD mutation (90)
FLT3 mutation (67)
RAS wild-type (17)
NRAS Q61K (15)
FLT3-TKD mutation (13)
FLT3 D835Y (12)
FLT3 F691L (11)
NRAS Q61 (10)
NRAS wild-type (10)
NRAS Q61R (9)
FLT3 D835 (8)
NRAS G12D (7)
FLT3 D835V (6)
FLT3-ITD mutation + FLT3-TKD mutation (5)
NRAS G12 (5)
NRAS G13 (5)
NRAS Q61L (5)
DNMT3A mutation + FLT3-ITD mutation (4)
FLT3 D698N (4)
FLT3 D835H (4)
FLT3 G697R (4)
FLT3 N676K (4)
FLT3 Y842C (4)
FLT3 mutation + NPM1 mutation (4)
NRAS Q61H (4)
NRAS mutation + BRAF mutation (4)
FLT3 N676D (3)
FLT3 N676D + FLT3 Y842C (3)
FLT3 N676T (3)
FLT3 mutation + DNMT3A mutation (3)
FLT3 wild-type (3)
FLT3-ITD mutation + FLT3 D835 (3)
FLT3-ITD mutation + MLL rearrangement (3)
FLT3-ITD mutation + NPM1 mutation (3)
FLT3‐ITD + NPM1 mutation (3)
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation (3)
NRAS A146T (3)
NRAS G13D (3)
NRAS G13N (3)
NRAS G13R (3)
NRAS Q61K + BRAF V600E (3)
NRAS exon 2 mutation (3)
NRAS exon 4 mutation (3)
FLT3 D835A (2)
FLT3 D835F (2)
FLT3 D835N (2)
FLT3 I836 (2)
FLT3 Y842H (2)
FLT3 mutation + MLL mutation (2)
FLT3-ITD mutation + FLT3 D835Y (2)
FLT3-ITD mutation + FLT3 F691L (2)
FLT3-ITD mutation + IDH1 mutation (2)
FLT3-ITD mutation + IDH2 mutation (2)
FLT3-ITD mutation + WT1 mutation (2)
FLT3‐ITD (2)
EGFR mutation + NRAS Q61K (2)
NRAS A146 (2)
NRAS A59 (2)
NRAS G12C + BRAF mutation (2)
NRAS H117 (2)
NRAS exon 3 mutation (2)
CEBPZ rearrangement + FLT3-TKD mutation (1)
FLT3 840GS (1)
FLT3 A627T (1)
FLT3 D651G (1)
FLT3 D835E (1)
FLT3 D835G (1)
FLT3 D839G (1)
FLT3 E588_Y589INSKYFYVDFRE (1)
FLT3 F691L + FLT3 D835F (1)
FLT3 F691L + FLT3 D835H (1)
FLT3 F691L + FLT3 D835V (1)
FLT3 F691L + FLT3 D835Y (1)
FLT3 F691L + FLT3 D839G (1)
FLT3 F691L + FLT3 Y842C (1)
FLT3 G619C (1)
FLT3 G846S (1)
FLT3 I687F (1)
FLT3 NPOS + FLT3 D835N (1)
FLT3 V592A + FLT3 D835N (1)
FLT3 V592_D593INSDFREY (1)
FLT3 Y591_V592INSVDFREYE (1)
FLT3 mutation + IDH1 mutation (1)
FLT3 mutation + NRAS mutation + PTPN11 mutation (1)
FLT3 mutation + PTPN11 mutation (1)
FLT3 positive (1)
FLT3-ITD F692L + NPM1 mutation (1)
FLT3-ITD mutation + ASXL1 mutation (1)
FLT3-ITD mutation + ASXL1 mutation + NRAS mutation (1)
FLT3-ITD mutation + DNMT3A mutation + ASXL1 mutation (1)
FLT3-ITD mutation + DNMT3A mutation + NRAS mutation (1)
FLT3-ITD mutation + FLT3 D835Y + FLT3 F691L (1)
FLT3-ITD mutation + NRAS mutation + GATA2 mutation (1)
FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
FLT3‐ITD + DNMT3A mutation (1)
FLT3‐ITD + WT1 mutation (1)
MLL rearrangement + FLT3 mutation (1)
NPM1 mutation + FLT3-ITD mutation + TET2 mutation + CUX1 mutation (1)
NPM1 mutation + FLT3-TKD mutation (1)
NPM1 mutation + SRSF2 mutation + FLT3-ITD mutation+ DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
ARAF mutation + NRAS mutation (1)
ASXL1 mutation + NRAS mutation (1)
BRAF wild-type + NRAS wild-type (1)
DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
DNMT3A mutation + NRAS mutation (1)
EGFR exon 20 insertion + NRAS G13V + NF1 R69fs + NF1 S340fs (1)
HRAS Q61L + NRAS Q61K (1)
IDH2 mutation + NRAS mutation (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
NPM1 mutation + NRAS mutation (1)
NRAS G115Efs*46 (1)
NRAS G12C + BRAF V600E + BRAF V600D (1)
NRAS G12S (1)
NRAS G12V (1)
NRAS G13D + BRAF V600E (1)
NRAS Q60H (1)
NRAS mutation + U2AF1 mutation (1)
SETBP1 mutation + NRAS mutation (1)
SRSF2 mutation + DNMT3A mutation + ASXL1 mutation + NRAS mutation (1)
TET2 mutation + NRAS mutation (1)
FLT3 A848P (0)
FLT3 F691I (0)
FLT3 F691L + FLT3 Y842H (0)
FLT3 V592A (0)
FLT3-ITD F692L (0)
NRAS G12C (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
cytarabine + idarubicin
Resistant: C3 – Early Trials
cytarabine + idarubicin
Resistant
:
C3
cytarabine + idarubicin
Resistant: C3 – Early Trials
cytarabine + idarubicin
Resistant
:
C3
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
gilteritinib
Sensitive: C3 – Early Trials
gilteritinib
Sensitive
:
C3
gilteritinib
Sensitive: C3 – Early Trials
gilteritinib
Sensitive
:
C3
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
FLT3 mutation + NRAS mutation
Acute Myelogenous Leukemia
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
gilteritinib + RMC-7977
Sensitive: D – Preclinical
gilteritinib + RMC-7977
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.